InsidersTradesSigma
Track the ValiRx PLC share price and the full directors' dealings record of the company, a listed equity based in United Kingdom. Shares trade on the UK market, under the oversight of RNS (LSE). Market capitalisation: €2.1m. The latest transaction was reported on 4 March 2026 (Purchase). Among the most active insiders: Mark Eccleston. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ValiRx PLC is a biopharmaceutical company focused on developing treatments for cancer and other diseases. It is listed on the London Stock Exchange.